Endogenous Hormones and Risk of Endometriosis

内源性激素和子宫内膜异位症的风险

基本信息

  • 批准号:
    7022519
  • 负责人:
  • 金额:
    $ 21.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-06-14 至 2010-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Endometriosis, the third leading cause of gynecologic hospitalization in the United States, remains one of the most enigmatic gynecologic pathologies. Defined by the presence of endometrial tissue outside of the uterus, these implants respond to the hormonal cues of the menstrual cycle and "bleed" as they would in the uterus. The consequence is the development of adhesions, scarring, and painful inflammation. Signs and symptoms include dysmenorrhea, dyspareunia, infertility, dysuria, and dyschezia. The effects of the disease can be physically and mentally debilitating with frequent misdiagnoses and limited treatment options. Despite the high morbidity and health care cost associated with endometriosis, its etiology has not been fully delineated, and no modifiable, protective risk factors have been confirmed. Using data on up to 2,000 laparoscopically confirmed incident cases of endometriosis collected from the Nurses Health Study II, an ongoing, prospective cohort study that began when 116,000 women were enrolled in 1989 . 30,000 of whom also provided blood samples in the late 1990s; we propose a study to assess the following hypotheses: a) Women who are more physically active are at lower risk of endometriosis. b) Paradoxically, women who were obese during childhood are at lower risk of endometriosis. c) Women who experienced longer durations of lactational amenorrhea are at lower risk of endometriosis. d) Women with higher plasma levels of testosterone or with lower levels of estradiol or insulin-like growth factors are at lower risk of endometriosis. All analyses will control for other known and suggested risk factors for endometriosis such as menstrual cycle characteristics, oral contraceptive use, and cigarette smoking. e) In addition, we will establish prospective investigation of endometriosis in the Growing Up Today Study . a cohort of daughters of NHSII participants who range in age from 18-23 in 2005. This provides a unique opportunity to lay the groundwork for future prospective investigations that extend our follow-up to the earliest points of endometriosis incidence as these young women have been providing exposure data since 1996. These analyses will provide the first prospective evaluation of physical activity, will be the first to investigate childhood body size or lactational amenorrhea, and will be the first to evaluate the relation between endogenous hormone levels and this important and understudied cause of morbidity among premenopausal women. Establishment of follow-up among our younger cohort will provide resources for the first prospective study of endometriosis among adolescents.
描述(由申请人提供):子宫内膜异位症,在美国妇科住院的第三大原因,仍然是最神秘的妇科病理之一。由子宫外的子宫内膜组织的存在定义,这些植入物对月经周期的激素提示做出反应,并像在子宫内一样“出血”。其后果是粘连、瘢痕形成和疼痛性炎症的发展。体征和症状包括痛经、性交困难、不孕、排尿困难和大便困难。这种疾病的影响可能会使身体和精神衰弱,经常误诊,治疗选择有限。尽管与子宫内膜异位症相关的高发病率和医疗费用,其病因尚未完全阐明,也没有可改变的保护性危险因素得到证实。使用从护士健康研究II中收集的多达2,000例腹腔镜证实的子宫内膜异位症事件病例的数据,这是一项正在进行的前瞻性队列研究,始于1989年116,000名妇女入组。其中30,000人在20世纪90年代末也提供了血液样本;我们提出了一项研究来评估以下假设:a)身体活动较多的女性患子宫内膜异位症的风险较低。B)奇怪的是,儿童时期肥胖的妇女患子宫内膜异位症的风险较低。c)哺乳期闭经持续时间较长的女性患子宫内膜异位症的风险较低。d)血浆睾酮水平较高或雌二醇或胰岛素样生长因子水平较低的女性患子宫内膜异位症的风险较低。所有分析将控制其他已知和建议的子宫内膜异位症风险因素,如月经周期特征,口服避孕药使用和吸烟。e)此外,我们将在今天的成长研究中建立子宫内膜异位症的前瞻性调查。一组2005年年龄在18-23岁之间的NHSII参与者的女儿。这提供了一个独特的机会,为未来的前瞻性研究奠定基础,将我们的随访扩展到子宫内膜异位症发病的最早点,因为这些年轻女性自1996年以来一直提供暴露数据。这些分析将首次提供对体力活动的前瞻性评价,首次调查儿童体型或哺乳期闭经,首次评价内源性激素水平与绝经前妇女发病的重要和未充分研究的原因之间的关系。在我们的年轻队列中建立随访将为青少年子宫内膜异位症的首次前瞻性研究提供资源。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STACEY ANN MISSMER其他文献

STACEY ANN MISSMER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STACEY ANN MISSMER', 18)}}的其他基金

Harnessing biomarker and phenotypic diversity among adolescents and women with endometriosis to advance personalized medicine for diagnosis and pain remediation
利用患有子宫内膜异位症的青少年和女性的生物标志物和表型多样性来推进诊断和疼痛治疗的个性化医疗
  • 批准号:
    9921458
  • 财政年份:
    2019
  • 资助金额:
    $ 21.46万
  • 项目类别:
Infertility History and Chronic Disease Profile
不孕史和慢性病概况
  • 批准号:
    10627758
  • 财政年份:
    2019
  • 资助金额:
    $ 21.46万
  • 项目类别:
Covid‐19 Vaccination and Menstrual Health
Covid-19 疫苗接种和月经健康
  • 批准号:
    10433013
  • 财政年份:
    2019
  • 资助金额:
    $ 21.46万
  • 项目类别:
Infertility History and Chronic Disease Profile
不孕史和慢性病概况
  • 批准号:
    10397585
  • 财政年份:
    2019
  • 资助金额:
    $ 21.46万
  • 项目类别:
Infertility History and Chronic Disease Profile
不孕史和慢性病概况
  • 批准号:
    9924593
  • 财政年份:
    2019
  • 资助金额:
    $ 21.46万
  • 项目类别:
Immunology, Inflammation, and Endometriosis
免疫学、炎症和子宫内膜异位症
  • 批准号:
    7996065
  • 财政年份:
    2008
  • 资助金额:
    $ 21.46万
  • 项目类别:
Immunology, Inflammation, and Endometriosis
免疫学、炎症和子宫内膜异位症
  • 批准号:
    7743012
  • 财政年份:
    2008
  • 资助金额:
    $ 21.46万
  • 项目类别:
Immunology, Inflammation, and Endometriosis
免疫学、炎症和子宫内膜异位症
  • 批准号:
    7528792
  • 财政年份:
    2008
  • 资助金额:
    $ 21.46万
  • 项目类别:
Immunology, Inflammation, and Endometriosis
免疫学、炎症和子宫内膜异位症
  • 批准号:
    8197666
  • 财政年份:
    2008
  • 资助金额:
    $ 21.46万
  • 项目类别:
Endogenous Hormones and Risk of Endometriosis
内源性激素和子宫内膜异位症的风险
  • 批准号:
    7248571
  • 财政年份:
    2006
  • 资助金额:
    $ 21.46万
  • 项目类别:

相似海外基金

Ovarian Function Among Samoan Women with Obesity
萨摩亚肥胖女性的卵巢功能
  • 批准号:
    10605790
  • 财政年份:
    2023
  • 资助金额:
    $ 21.46万
  • 项目类别:
Investigation of brainstem neurons in the regulation of gonadotropin secretion
脑干神经元调节促性腺激素分泌的研究
  • 批准号:
    10743067
  • 财政年份:
    2023
  • 资助金额:
    $ 21.46万
  • 项目类别:
Evolution of non-reproductive sexual behavior: Sexual receptivity during postpartum amenorrhea in bonobos
非生殖性行为的进化:倭黑猩猩产后闭经期间的性接受能力
  • 批准号:
    23KK0130
  • 财政年份:
    2023
  • 资助金额:
    $ 21.46万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
The Genetics and penetrance of the Mullerian Anomalies: Addressing the Challenges of the bench to bedside gap.
苗勒管异常的遗传学和外显率:解决替补与床边差距的挑战。
  • 批准号:
    10668122
  • 财政年份:
    2023
  • 资助金额:
    $ 21.46万
  • 项目类别:
Elucidating the mechanisms of protein secretion across the outer membrane by bacterial autotransporters
阐明细菌自转运蛋白跨外膜分泌蛋白质的机制
  • 批准号:
    10736193
  • 财政年份:
    2023
  • 资助金额:
    $ 21.46万
  • 项目类别:
Estrogen Declines with Menopause: Impacts on the Medial Temporal Lobe Network and Emotional Memory in Aging Females at Genetic Risk for Alzheimer’s Disease
雌激素随更年期下降:对有阿尔茨海默病遗传风险的老年女性内侧颞叶网络和情绪记忆的影响
  • 批准号:
    10607612
  • 财政年份:
    2023
  • 资助金额:
    $ 21.46万
  • 项目类别:
Deciphering the Role of Copy Number Variants in Neuroendocrine Disorders of Infertility
解读拷贝数变异在不孕症神经内分泌疾病中的作用
  • 批准号:
    10463237
  • 财政年份:
    2022
  • 资助金额:
    $ 21.46万
  • 项目类别:
Investigation of Social and Circadian Rhythm Dysregulation in the Development of Depression Symptoms During the Menopause Transition
更年期过渡期间抑郁症状发展中社会和昼夜节律失调的调查
  • 批准号:
    10507660
  • 财政年份:
    2022
  • 资助金额:
    $ 21.46万
  • 项目类别:
Live nasal recombinant B. pertussis vaccine against tuberculosis
鼻用重组百日咳杆菌结核活疫苗
  • 批准号:
    10442002
  • 财政年份:
    2022
  • 资助金额:
    $ 21.46万
  • 项目类别:
Deciphering the Role of Copy Number Variants in Neuroendocrine Disorders of Infertility
解读拷贝数变异在不孕症神经内分泌疾病中的作用
  • 批准号:
    10663071
  • 财政年份:
    2022
  • 资助金额:
    $ 21.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了